India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Former DCGI and now advisor to UP CM highlights medical device growth, healthcare expansion, and investment opportunities in the state
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy
Approval strengthens the company’s growing international anti-infective portfolio
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Keeps Halo Pharma to drive independent growth
Subscribe To Our Newsletter & Stay Updated
